Targimmune Therapeutics Ag

Calculating rank

USPTO Granted Patents = 6

EPO Patents = 2

Trademarks = 1

Forward Citations = 8

Loading Chart...

10 inventors (with patents filed for the assignee):

Yael Langut (6 out of 6 patents)

Alexei Shir (4 out of 8 patents)

Maya Zigler (4 out of 4 patents)

4. Alex Levitzki (3 out of 10 patents)

5. Salim Joubran (3 out of 3 patents)

6. Alaa Talhami (3 out of 3 patents)

7. Alexander Levitzki (3 out of 41 patents)

8. Nufar Edinger (1 out of 1 patent)

9. Esteban Pombo-Villar (1 out of 1 patent)

10. Eric Kitas (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 11912747 - Chimeric proteins for targeting dsRNA (2024-02-27),

2. 11679160 - Castration resistant prostate cancer (2023-06-20),

3. 11298376 - Method of treating cancer (2022-04-12),

4. 11230580 - Chimeric proteins for targeting dsRNA (2022-01-25),

5. 10543232 - Polyplex of double-stranded RNA and polymeric conjugate (2020-01-28),

6. 10278991 - Polyethyleneimine polyethyleneglycol vectors (2019-05-07),

Company Overview

Targimmune Therapeutics Ag is a biotechnology company focused on the development of novel cancer immunotherapies. Utilizing cutting-edge technologies, Targimmune is dedicated to advancing personalized therapies that harness the immune system to target and eliminate cancer cells. The company's innovative approach has the potential to revolutionize cancer treatment and improve patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

6 Patents

#54 in Basel

#1,483 in Switzerland

Basel, Switzerland

Targimmune Therapeutics Ag

Forward Citations = 8

10 inventors:

Yael Langut (6 out of 6 patents)

Alexei Shir (4 out of 8 patents)

Maya Zigler (4 out of 4 patents)

4. Alex Levitzki (3 out of 10 patents)

5. Salim Joubran (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Targimmune Therapeutics Ag. Retrieved from https://idiyas.com/company/targimmune-therapeutics-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]